Page 109 - journal-13-2-S-Full
P. 109

100




              Session 2: Clinical studies and clinical application of traditional & indigenous medicine



             Efficacy and Safety of the Sahastara remedy versus Diclofenac in

             the Treatment of Osteoarthritis of the Knee: A Double Blind,
             Randomized Controlled Trial

                                                                             ,
             Puritat Kanokkangsadal*, Piya Pinsornsak**, Arunporn Itharat*****
             *Department of Orthopedics, Faculty of Medicine, **Department of Applied Thai Traditional Medi-
             cine, ***Center of Excellence on Applied Thai Traditional Medicine Research (CEATMR), Faculty of
             Medicine, Thammasat University, Pathumthani, 12120, Thailand

                 Background and Rationale: The Sahastara (SHT) remedy is a Thai traditional medicine
             that has been acknowledged in the Thai National List of Essential Medicines and has been
             used as an alternative medicine to treat knee osteoarthritis (OA). Although, SHT remedies
             have been used in Thai traditional medical practices for a long period of time, there are few
             reports on their clinical trials.
                 Objective: To investigate the clinical efficacy and safety of the SHT remedy in treating
             OA of the knee when compared to diclofenac.
                 Methods: A phase 2, double-blind, randomized controlled trial study was conducted to
             determine the clinical efficacy and safety of SHT in comparison with diclofenac for the treat-
             ment of knee OA. Sixty six patients, ages between 45›80 years of age were randomly allocated
             into 2 groups. The SHT group received 1,000 mg of SHT powdered capsules 3 times per day,
             orally before meals, while another group received 25 mg of diclofenac sodium capsules 3 times
             a day, orally after meals for 28 days. Both groups received placebos to maintain the double-
             blind conditions and Omeprazole 20 mg, twice daily, orally before meals for GI prophylaxis. All
             patients were followed up at 14 and 28 days for the evaluation of the efficacy and safety by
             using clinical examinations, blood tests, a visual analogue scale (VAS) for pain, and the 100
             meter walk-time test. Improvement on the quality of life was also assessed by the WOMAC
             index.
                 Results: There were 31 and 30 patients in SHT and diclofenac groups, respectively, who
             had completed the study. Both medications have shown to significantly improve the VAS for
             pain, the 100 meter walk-time test and the WOMAC index score. However, there were no
             differences in the efficacy between the two groups. Abdominal discomfort was the most
             frequent adverse event found in both groups. The blood chemistry showed no toxicity on renal
             and/or liver functions but the patients taking diclofenac showed significant increases in their
             AST, ALT, and ALP. Systolic and diastolic blood pressures slightly increased in the diclofenac
             group but were not altered in the SHT group.
                 Conclusions: The SHT remedy similar to diclofenac in all evaluating symptoms of knee
             OA. However, the SHT remedy has shown to be a good alternative treatment for knee OA with
             less systemic side effects when it was compared with diclofenac.
                 Key words: Sahastara remedy, OA knee, diclofenac, alternative medicine, Thai tradi-
             tional medicine
   104   105   106   107   108   109   110   111   112   113   114